The Journal of Biotechnology has recently published an article discussing the work leading up to the development BMB’s separatome platform. […]Read More
Boston Mountain Biotech
At Boston Mountain Biotech, we develop and patent technology that aids in the development of a new protein expression and purification platform. Currently this technology is being marketed through the Lotus® E. coli Cell Lines which demonstrate reduced host cell protein (HCP). These new reduced HCP bacterial cell lines simplify the development and manufacturing of recombinant protein therapeutics, vaccines and enzymes. At BMB, we are revolutionizing the pharmaceutical industry by providing protein purification solutions that result in new drugs moving from development to patient faster while simultaneously lowering the cost of manufacturing.
In The Media
September 11, 2014
July 25, 2014
Congratulations to both the University of Arkansas and the University of Pittsburgh for being ranked #68 and #33 respectively in […]Read More